Pliant Therapeutics IncNASDAQ:PLRX
- LAST PRICE11.3100
- TODAY'S CHANGE (%)0.1400 (1.2534%)
- Bid / Lots11.0000/ 3
- Ask / Lots13.3500/ 1
- Open / Previous Close11.3300 / 11.1700
- Day Range
- 52 Week Range
- Volume215,983
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PLRX |
|---|---|---|
| 09:32 ET | 3781 | 11.47 |
| 09:38 ET | 200 | 11.34 |
| 09:39 ET | 500 | 11.365 |
| 09:41 ET | 200 | 11.42 |
| 09:43 ET | 200 | 11.42 |
| 09:50 ET | 920 | 11.375 |
| 09:54 ET | 1000 | 11.435 |
| 09:57 ET | 2456 | 11.45 |
| 10:01 ET | 739 | 11.47 |
| 10:03 ET | 700 | 11.505 |
| 10:06 ET | 205 | 11.4839 |
| 10:08 ET | 1635 | 11.51 |
| 10:10 ET | 200 | 11.52 |
| 10:12 ET | 300 | 11.53 |
| 10:14 ET | 600 | 11.49 |
| 10:21 ET | 100 | 11.52 |
| 10:28 ET | 100 | 11.55 |
| 10:30 ET | 100 | 11.57 |
| 10:33 ET | 1000 | 11.54 |
| 10:35 ET | 400 | 11.55 |
| 10:39 ET | 300 | 11.57 |
| 10:46 ET | 600 | 11.58 |
| 10:50 ET | 311 | 11.6062 |
| 10:51 ET | 1424 | 11.555 |
| 10:53 ET | 600 | 11.51 |
| 10:57 ET | 1200 | 11.47 |
| 11:00 ET | 200 | 11.49 |
| 11:04 ET | 100 | 11.48 |
| 11:06 ET | 100 | 11.48 |
| 11:09 ET | 100 | 11.48 |
| 11:11 ET | 100 | 11.505 |
| 11:18 ET | 1096 | 11.51 |
| 11:20 ET | 200 | 11.515 |
| 11:22 ET | 400 | 11.47 |
| 11:24 ET | 692 | 11.44 |
| 11:26 ET | 100 | 11.395 |
| 11:40 ET | 1292 | 11.38 |
| 11:42 ET | 321 | 11.4 |
| 11:44 ET | 800 | 11.43 |
| 11:56 ET | 100 | 11.44 |
| 11:58 ET | 300 | 11.45 |
| 12:00 ET | 100 | 11.45 |
| 12:02 ET | 200 | 11.445 |
| 12:03 ET | 200 | 11.46 |
| 12:05 ET | 600 | 11.44 |
| 12:07 ET | 300 | 11.42 |
| 12:09 ET | 1000 | 11.435 |
| 12:16 ET | 1100 | 11.39 |
| 12:18 ET | 500 | 11.43 |
| 12:20 ET | 115 | 11.435 |
| 12:21 ET | 100 | 11.435 |
| 12:23 ET | 226 | 11.42 |
| 12:25 ET | 497 | 11.4 |
| 12:30 ET | 962 | 11.368 |
| 12:32 ET | 803 | 11.385 |
| 12:34 ET | 200 | 11.38 |
| 12:36 ET | 100 | 11.37 |
| 12:38 ET | 500 | 11.39 |
| 12:39 ET | 119 | 11.39 |
| 12:43 ET | 700 | 11.38 |
| 12:45 ET | 280 | 11.37 |
| 12:48 ET | 800 | 11.365 |
| 12:50 ET | 100 | 11.36 |
| 12:56 ET | 300 | 11.36 |
| 12:57 ET | 108 | 11.355 |
| 12:59 ET | 182 | 11.36 |
| 01:01 ET | 700 | 11.37 |
| 01:03 ET | 639 | 11.39 |
| 01:08 ET | 2600 | 11.4 |
| 01:10 ET | 600 | 11.46 |
| 01:14 ET | 600 | 11.48 |
| 01:19 ET | 100 | 11.5 |
| 01:24 ET | 484 | 11.515 |
| 01:26 ET | 1800 | 11.455 |
| 01:30 ET | 200 | 11.485 |
| 01:32 ET | 100 | 11.49 |
| 01:35 ET | 399 | 11.4984 |
| 01:37 ET | 100 | 11.5 |
| 01:39 ET | 100 | 11.47 |
| 01:42 ET | 100 | 11.47 |
| 01:46 ET | 760 | 11.47 |
| 01:48 ET | 311 | 11.48 |
| 01:50 ET | 200 | 11.49 |
| 01:51 ET | 100 | 11.48 |
| 01:55 ET | 100 | 11.49 |
| 02:00 ET | 408 | 11.48 |
| 02:04 ET | 201 | 11.48 |
| 02:06 ET | 1000 | 11.43 |
| 02:08 ET | 100 | 11.415 |
| 02:09 ET | 100 | 11.415 |
| 02:13 ET | 1740 | 11.46 |
| 02:15 ET | 100 | 11.48 |
| 02:20 ET | 500 | 11.44 |
| 02:22 ET | 100 | 11.45 |
| 02:24 ET | 100 | 11.47 |
| 02:26 ET | 100 | 11.43 |
| 02:27 ET | 300 | 11.42 |
| 02:29 ET | 2764 | 11.4179 |
| 02:31 ET | 400 | 11.42 |
| 02:33 ET | 900 | 11.42 |
| 02:36 ET | 352 | 11.41 |
| 02:38 ET | 1086 | 11.4 |
| 02:40 ET | 300 | 11.4 |
| 02:42 ET | 600 | 11.418 |
| 02:44 ET | 1175 | 11.43 |
| 02:47 ET | 700 | 11.44 |
| 02:51 ET | 529 | 11.46 |
| 02:54 ET | 1038 | 11.44 |
| 02:56 ET | 100 | 11.45 |
| 02:58 ET | 200 | 11.47 |
| 03:00 ET | 1425 | 11.465 |
| 03:02 ET | 300 | 11.45 |
| 03:03 ET | 100 | 11.45 |
| 03:05 ET | 1812 | 11.45 |
| 03:07 ET | 1728 | 11.44 |
| 03:09 ET | 118 | 11.445 |
| 03:14 ET | 1500 | 11.43 |
| 03:16 ET | 100 | 11.43 |
| 03:18 ET | 700 | 11.41 |
| 03:20 ET | 271 | 11.42 |
| 03:21 ET | 335 | 11.41 |
| 03:23 ET | 1043 | 11.4 |
| 03:25 ET | 695 | 11.3999 |
| 03:27 ET | 200 | 11.4 |
| 03:30 ET | 600 | 11.42 |
| 03:32 ET | 300 | 11.42 |
| 03:34 ET | 619 | 11.41 |
| 03:36 ET | 2000 | 11.41 |
| 03:38 ET | 1100 | 11.395 |
| 03:39 ET | 300 | 11.4 |
| 03:41 ET | 900 | 11.4 |
| 03:43 ET | 2259 | 11.415 |
| 03:45 ET | 1033 | 11.405 |
| 03:48 ET | 456 | 11.41 |
| 03:50 ET | 1730 | 11.405 |
| 03:52 ET | 1844 | 11.405 |
| 03:54 ET | 3596 | 11.42 |
| 03:56 ET | 1482 | 11.42 |
| 03:57 ET | 5521 | 11.38 |
| 03:59 ET | 44772 | 11.31 |
Sep 24, 2024
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer, from 8:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 13, 2024
DJ Pliant Therapeutics Price Target Maintained With a $38.00/Share by HC Wainwright & Co., from 7:08AM ET on Friday Sep 13, 2024 by Dow Jones
7:08AM ET on Friday Sep 13, 2024 by Dow Jones
Sep 10, 2024
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024, from 8:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
DJ Pliant Therapeutics Coverage Assumed by Leerink Partners at Outperform, from 9:10AM ET on Monday Sep 09, 2024 by Dow Jones
9:10AM ET on Monday Sep 09, 2024 by Dow Jones
Aug 28, 2024
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors, from 8:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
8:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pliant Therapeutics Inc | 679.2M | -3.7x | --- |
Liquidia Corp | 851.7M | -6.4x | --- |
Petro USA Inc | 1.0B | -31,250.0x | --- |
Precigen Inc | 260.5M | -1.8x | --- |
ASP Isotopes Inc | 194.7M | -4.3x | --- |
Telomir Pharmaceuticals Inc | 191.3M | -9.9x | --- |
Company Information
Pliant Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Its lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of αvß6 and αvß1 integrins that is in development in the lead indications for the treatment of idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). The Company has initiated BEACON-IPF, a Phase 2b trial of bexotegrast in IPF. It has also developed PLN-1474, a small molecule, selective inhibitor of αvß1 integrin for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis. It has initiated a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company has a preclinical program, PLN-101325, targeting muscular dystrophies.
Contact Information
- Headquarters
- 331 Oyster Point BoulevardSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-481-6770
- Fax
- ---
Executives
- Non-Executive Chairman of the Board, Lead Independent Director
- Hoyoung Huh
- President, Chief Executive Officer, Director
- Bernard Coulie
- Chief Financial Officer
- Keith Cummings
- Chief Human Resource Officer
- Lily Cheung
- General Counsel, Corporate Secretary
- Mike Ouimette
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $679.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 60.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-3.09 |
Book Value | $7.90 |
P/E Ratio | -3.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
